Cargando…
Diagnostic and therapeutic value of P2Y12R in epilepsy
There lacks biomarkers in current epilepsy diagnosis, and epilepsy is thus exposed to inadequate treatment, making it necessarily important to conduct search on new biomarkers and drug targets. The P2Y12 receptor is primarily expressed on microglia in the central nervous system, and acts as intrinsi...
Autores principales: | Chen, Xiang, Wang, Qi, Yang, Jie, Zhang, Li, Liu, Ting-Ting, Liu, Jun, Deng, Bin-Lu, Liu, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206044/ https://www.ncbi.nlm.nih.gov/pubmed/37234715 http://dx.doi.org/10.3389/fphar.2023.1179028 |
Ejemplares similares
-
P2Y12 receptor gene polymorphisms are associated with epilepsy
por: Wang, Qi, et al.
Publicado: (2022) -
Association of the ADORA2A receptor and CD73 polymorphisms with epilepsy
por: Shi, Nan-Rui, et al.
Publicado: (2023) -
Initial therapeutic target attainment of perampanel in pediatric patients with epilepsy
por: Yu, Lingyan, et al.
Publicado: (2023) -
Evaluation of Tolerability, Pharmacokinetics and Pharmacodynamics of Vicagrel, a Novel P2Y12 Antagonist, in Healthy Chinese Volunteers
por: Li, Xiaojiao, et al.
Publicado: (2018) -
Targeting ferroptosis as novel therapeutic approaches for epilepsy
por: Jin, Yuzi, et al.
Publicado: (2023)